skip to Main Content

Women's Venture Competition

Women’s Venture Competition review committees are comprised of a combination of world-class life sciences industry professionals, investors and entrepreneurs from within the extensive network of the National Foundation for Cancer Research, the non-profit affiliate of the AIM-HI Accelerator Fund.

The winner of the Women’s Venture Competition will receive an equity investment of $300,000 from the AIM-HI Accelerator Fund. These funds will serve as seed money for proof of concept and proof of value on the path to clinical trials, and eventually, to new effective therapeutics and diagnostics that will eventually save patients’ lives.

Ready to do more? DONATE NOW and help us double the impact for women scientist-entrepreneurs who are creating life-saving oncology innovations!

Investment Committee:

Jimmy Lu, J.D., MBA, Chair

Jimmy Lu, J.D., MBA, Chair

Managing Director, WI Harper Group

Dimitra Georganopoulou, Ph.D.

Dimitra Georganopoulou, Ph.D.

Innovation Faculty, MIT linQ CATALYST

Raju Kucherlapati, Ph.D.

Raju Kucherlapati, Ph.D.

Paul C. Cabot Professor of Genetics & Professor of Medicine, Harvard Medical School

Matt Tremblay, Ph.D.

Matt Tremblay, Ph.D.

Chief Operating Officer, Scripps Research

Michael Wang, M.D., Ph.D., MBA

Michael Wang, M.D., Ph.D., MBA

CSO, National Foundation for Cancer Research

Rose Wang, MBA

Rose Wang, MBA

Executive Advisor, AIM-HI Accelerator Fund

Yajun Xu, Ph.D.

Yajun Xu, Ph.D.

Managing Parrtner, Hongsen Capital

Judging Committee:

Barbara Weber, M.D., Chair

Barbara Weber, M.D., Chair

President & CEO, Tango Therapeutics

Raju Kucherlapati, Ph.D., Co-Chair

Raju Kucherlapati, Ph.D., Co-Chair

Paul C. Cabot Professor of Genetics & Professor of Medicine, Harvard Medical School

Joan Brugge, Ph.D.

Joan Brugge, Ph.D.

Louise Foote Pfeiffer Professor of Cell Biology & Director of Ludwig Center, Harvard Medical School

Webster Cavenee, Ph.D.

Webster Cavenee, Ph.D.

Director of Strategic Alliances, Ludwig Institute for Cancer Research

Pamela Garzone, Ph.D.

Pamela Garzone, Ph.D.

Chief Medical Officer, Calibr at Scripps Research

Tom Miller

Tom Miller

Founder & Managing Partner, GreyBird Ventures

Amy Millman

Amy Millman

President & Co-Founder, Springboard Enterprises

Robert Tepper, M.D.

Robert Tepper, M.D.

Partner, Third Rock Ventures

Selection Committee:

Pamela Garzone, Ph.D., Chair

Pamela Garzone, Ph.D., Chair

Chief Medical Officer, Calibr at Scripps Research

Webster Cavenee, Ph.D., Co-chair

Webster Cavenee, Ph.D., Co-chair

Director of Strategic Alliances, Ludwig Institute for Cancer Research

Dimitra Georganopoulou, Ph.D.

Dimitra Georganopoulou, Ph.D.

Innovation Faculty, MIT linQ CATALYST
Interim Chief Business Officer, MyGenome Rx

Marjorie Kaufman, CFA, MBA

Marjorie Kaufman, CFA, MBA

Principal, Osprey Creek LLC

Brian Leyland-Jones, M.B., B.S., Ph.D.

Brian Leyland-Jones, M.B., B.S., Ph.D.

Chief Medical Officer, AIM-HI Accelerator Fund

Patty Obermaier

Patty Obermaier

Vice President, US Health and Life Sciences, Microsoft

Marina Sirota, Ph.D.

Marina Sirota, Ph.D.

Assistant Professor, Institute for Computational Health Sciences, University of California San Francisco

Ashim Subedee, Ph.D.

Ashim Subedee, Ph.D.

Program Director, National Cancer Institute Small Business Innovation Research (SBIR) Development Center

Thea Tlsty, Ph.D.

Thea Tlsty, Ph.D.

Professor of Pathology, University of California San Francisco

Back To Top